Viatris Inc.

Viatris is a global healthcare company that supplies high-quality medicines to approximately 1 billion patients worldwide each year. The company operates in more than 165 countries and territories and employs more than 30,000 people. Viatris has 27 manufacturing, packaging, and distribution sites globally and an extensive portfolio of over 1,400 approved molecules. Its portfolio includes generics (including complex products), globally recognized iconic brands, and an expanding portfolio of innovative medicines. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China, and Hyderabad, India. In November 2022, Viatris completed a transaction to contribute its biosimilars portfolio to Biocon Biologics, receiving a combination of cash and stock in the form of CCPS, representing an approximately 12.9% stake (on a fully diluted basis) in Biocon Biologics.